OmniAb (OABI) Non-Current Deffered Revenue (2021 - 2026)

OmniAb's (OABI) quarterly Non-Current Deffered Revenue came in at $400000.0 in Q1 2026, up 852.38% on a QoQ basis from $42000.0 in Q2 2025.

OmniAb (OABI) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Non-Current Deffered Revenue data on file, last reported at $400000.0 in Q1 2026.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $400000.0 in Q1 2026; TTM through Mar 2026 was $400000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $117000.0, down 86.43% from the prior year.
  • Non-Current Deffered Revenue for Q1 2026 stood at $400000.0, up from $42000.0 in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for OABI reached as high as $4.3 million in Q4 2022 and fell as low as $41000.0 in Q3 2024.
  • Historically, Non-Current Deffered Revenue has averaged $1.3 million across 5 years, with a median of $400000.0 in 2026.
  • Across the five-year window, Non-Current Deffered Revenue slumped 97.93% in 2024 and tumbled 41.67% in 2025, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $4.3 million in 2022, then plunged by 80.07% to $862000.0 in 2023, then tumbled by 86.43% to $117000.0 in 2024, then sank by 64.1% to $42000.0 in 2025, then jumped by 852.38% to $400000.0 in 2026.
  • Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $400000.0 in Q1 2026, $42000.0 in Q2 2025, and $117000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn 400,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 400,000.00
Jun 30, 2025 42,000.00
Dec 31, 2024 117,000.00
Sep 30, 2024 41,000.00
Jun 30, 2024 72,000.00
Mar 31, 2024 279,000.00
Dec 31, 2023 862,000.00
Sep 30, 2023 1.95 Mn
Jun 30, 2023 3.48 Mn
Mar 31, 2023 3.02 Mn
Dec 31, 2022 4.33 Mn
Dec 31, 2021 9.23 Mn